▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
March 28, 2024

Market Now

Cellumed’s implant material wins USFDA approval

  • PUBLISHED :April 12, 2018 - 14:13
  • UPDATED :April 12, 2018 - 14:13
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[DISCLOSURE] Cellumed (049180) announced on April 12 that its implant material Rafugen DBM has won approval from USFDA. 

By Hwang You-mee (glamazon@heraldcorp.com)

EDITOR'S PICKS